(Brussels:ARGX),(NASDAQ:ARGX), May 28, 2025 – 10:01 PM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced the results of its Annual General Meeting of shareholders held on May 27, 2025. 91.1% of the Company's share capital […]
Taysha Gene Therapies Announces Pivotal Part B Trial Design Details for TSHA-102 in Rett Syndrome Enabled by IRSF Natural History Data and Positive Clinical Data from Part A of the REVEAL Adult/Adolescent and Pediatric Trials Evaluating TSHA-102 GlobeNewswire May 28, 2025 Natural history data analysis established patients greater-than or equal to six years of age
Corvus Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference GlobeNewswire May 28, 2025 SOUTH SAN FRANCISCO, Calif., May 28, 2025 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team will conduct one-on-one meetings with investors and present a corporate overview at the
Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress GlobeNewswire May 28, 2025 PHILADELPHIA, May 28, 2025 (GLOBE NEWSWIRE) — Century Therapeutics, Inc. ('Century', NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today announced two presentations at the upcoming European Alliance of
Nutanix Reports Third Quarter Fiscal 2025 Financial Results GlobeNewswire May 28, 2025 Delivers Outperformance Across All Guided Metrics Reports 18% YoY ARR Growth and Strong Free Cash Flow SAN JOSE, Calif., May 28, 2025 (GLOBE NEWSWIRE) — Nutanix, Inc. (NASDAQ: NTNX), a leader in hybrid multicloud computing, today announced financial results for its third quarter
argenx Announces Results of Annual General Meeting of Shareholders GlobeNewswire May 28, 2025 May 28, 2025 – 10:01 PM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced the results of its Annual General Meeting of
Disc Medicine to Participate in Upcoming Investor Conferences GlobeNewswire May 28, 2025 WATERTOWN, Mass., May 28, 2025 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will participate in fireside chats
EyePoint Announces Participation at Upcoming Investor Conferences GlobeNewswire May 28, 2025 WATERTOWN, Mass., May 28, 2025 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that company management will participate in fireside chats at the
(NASDAQ:DFDV),(NASDAQ:JNVR), BOCA RATON, FL, May 28, 2025 (GLOBE NEWSWIRE) — DeFi Development Corp. (Nasdaq: DFDV) (the “Company”) today announced that it will host a live X Spaces conversation on Friday, May 30, 2025, at 1:00 p.m. Eastern Time, titled “Validators 101: Powering Solana's Future.” The live conversation will feature leaders from Sanctum, the protocol behind
(NASDAQ:CRBU), BERKELEY, Calif., May 28, 2025 (GLOBE NEWSWIRE) — Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz, PhD, Caribou's president and chief executive officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 4th at 9:20 AM EDT. For more information and